LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

Inicio・Lista de Acciones・CorMedix Inc

CorMedix Inc

Abierto

SectorSanidad

11.33 -1.05

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

11.04

Máximo

11.5

Métricas clave
By Trading Economics
Ingresos	89M 109M
Ventas	65M 104M
P/B Media del Sector	5.095 77.671
BPA	0.28
Margen de beneficios	104.112
Empleados	64
EBITDA	37M 57M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+52.31% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	19M 887M
Apertura anterior	12.38
Cierre anterior	11.33

Noticias sobre sentimiento de mercado

By Acuity

26%

74%

51 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

9.2 / N/A Soporte y Resistencia

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 dic 2025, 22:53 UTC

Adquisiciones, fusiones, absorciones

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

13 dic 2025, 00:04 UTC

Adquisiciones, fusiones, absorciones

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

14 dic 2025, 23:46 UTC

Charlas de Mercado

Gold Edges Higher Amid Some Tailwinds -- Market Talk

14 dic 2025, 23:36 UTC

Charlas de Mercado

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

14 dic 2025, 22:38 UTC

Adquisiciones, fusiones, absorciones

Fortescue to Take Full Control of US$101M Copper Miner Alta

14 dic 2025, 22:02 UTC

Adquisiciones, fusiones, absorciones

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

14 dic 2025, 22:01 UTC

Adquisiciones, fusiones, absorciones

Fortescue: Alta Owns the Canariaco Project in Northern Peru

14 dic 2025, 22:01 UTC

Adquisiciones, fusiones, absorciones

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

14 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Fortescue: Agreement Implies Total Equity Value of C$139 Million

14 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

14 dic 2025, 21:59 UTC

Adquisiciones, fusiones, absorciones

Fortescue to Acquire Remaining 64% of Alta Copper

14 dic 2025, 17:00 UTC

Ganancias

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

14 dic 2025, 08:30 UTC

Adquisiciones, fusiones, absorciones

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

13 dic 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 dic 2025, 08:00 UTC

Adquisiciones, fusiones, absorciones

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 dic 2025, 07:00 UTC

Adquisiciones, fusiones, absorciones

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13 dic 2025, 00:24 UTC

Adquisiciones, fusiones, absorciones

Want a Piece Of SpaceX? -- Barrons.com

12 dic 2025, 23:49 UTC

Adquisiciones, fusiones, absorciones

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 dic 2025, 22:52 UTC

Charlas de Mercado

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 dic 2025, 22:32 UTC

Ganancias

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

12 dic 2025, 20:45 UTC

Ganancias

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 dic 2025, 20:41 UTC

Charlas de Mercado

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 dic 2025, 20:20 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 dic 2025, 19:23 UTC

Ganancias

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 dic 2025, 18:35 UTC

Adquisiciones, fusiones, absorciones

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 dic 2025, 18:33 UTC

Adquisiciones, fusiones, absorciones

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 dic 2025, 18:31 UTC

Charlas de Mercado

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 dic 2025, 17:49 UTC

Ganancias

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 dic 2025, 17:34 UTC

Adquisiciones, fusiones, absorciones

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

52.31% repunte

Estimación a 12 Meses

Media 17.5 USD 52.31%

Máximo 22 USD

Mínimo 14 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para CorMedix Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

51 / 374 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.